Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S, Remesova H, Valentova I, Lysak D, Holubova M, Kaspar P, Prochazka J, Kasikova L, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Among authors: salek c. Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w. Cell Death Dis. 2023. PMID: 36964168 Free PMC article.
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.
Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Fucikova J, et al. Among authors: salek c. Front Immunol. 2015 Aug 7;6:402. doi: 10.3389/fimmu.2015.00402. eCollection 2015. Front Immunol. 2015. PMID: 26300886 Free PMC article. Review.
Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Fucikova J, et al. Among authors: salek c. Blood. 2016 Dec 29;128(26):3113-3124. doi: 10.1182/blood-2016-08-731737. Epub 2016 Nov 1. Blood. 2016. PMID: 27802968 Free PMC article.
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline JP, Galluzzi L, Spisek R, Fucikova J. Truxova I, et al. Among authors: salek c. Haematologica. 2020 Jul;105(7):1868-1878. doi: 10.3324/haematol.2019.223933. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582537 Free PMC article.
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia.
Šálek C, Vydra J, Cerovská E, Šestáková Š, Ransdorfová Š, Válková V, Cetkovský P, Remešová H. Šálek C, et al. Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):e998-e1009. doi: 10.1016/j.clml.2020.07.014. Epub 2020 Aug 10. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32888885
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: salek c. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.
40 results